Funded Tech Companies
BioEclipse Therapeutics
BioEclipse Therapeutics, operating out of San Francisco, received equity investments through DEFTA Partners, TEEC Angel and Foothill Ventures.
Company Overview
Company Name
BioEclipse Therapeutics
Company Status
Private & Independent
Industry
Funding Rounds
Total Funding
Contact Information
Mailing Address
329 Oyster Point Blvd. 3rd Floor S.
San Francisco, CA 94080
USA
San Francisco, CA 94080
USA
Phone
Website
Email Address
Company Background Information
Overview
BioEclipse Therapeutics is an emerging, clinical-stage biopharmaceutical company committed to delivering first-in-class, curative immune-oncology therapeutics to patients with cancer. Our focus is on currently untreatable cancers where our unique approach may be able to address needs of patients with cancers that most think not possible.
Profile
Social Media
Company News
Facebook
YouTube
Last Transaction
6/25/2019
Financing History
Date
Type
Amount
Management Team
Title
Name
Email & Social
Chairman
Catherine Sohn
Chief Executive Officer
Pamela Contag
Chief Financial Officer
Benjamin Carter
Co-Founder
Christopher Contag
Co-Founder
Robert Negrin
Company Investors
- DEFTA Partners
- TEEC Angel
- Foothill Ventures
- Revelis Capital (Oliver Hopkinson)
- Plum Alley Investments
Browse more funded tech companies:
BioDuro | BioEnergy International
Share this article
About Our VC Transaction Database
This tech company profile is powered by VentureDeal.com, a market leader in private equity transaction data.
Additional Resources for Entrepreneurs